ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous select...
Leadership
Bruce Culleton M.D.
CEO & Director
James Coulston CPA
Chief Financial Officer
Todd C. Girolamo Esq., J.D., M.B.A.
Chief Legal Officer & Secretary
Ulrich Ernst Ph.D.
EVP of Science and Technology
Richard Williams
Chief Information Officer
Carla Poulson
Chief People Officer
Joseph M. Stavas M.D., M.P.H.
SVP of Clinical Affairs
Darin J. Weber Ph.D.
Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access
